Is enasidenib plus azacitidine better than with azacitidine alone for AML patients?

Bookmark and Share
Published: 24 Dec 2019
Views: 344
Dr Courtney DiNardo - MD Anderson Cancer Center, Houston, USA

Dr Courtney DiNardo speaks to ecancer at the ASH 2019 meeting in Orlando about enasidenib plus azacitidine when treating older patients with AML.

The study looked at enasidenib plus azacitidine vs with just azacitidine in newly diagnosed AML patients with IDH2 mutations.

Dr DiNardo explains the positive results and that the combination improves response rates without concerning toxicity.